Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel for GAD in Patients with Remitted Opiate Dependence
NCT00668265Phase 4Terminated
- Sponsor
- Mount Sinai Beth Israel
- Start
- Jan 2008
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine in generalized anxiety disorder (GAD), sponsored by Mount Sinai Beth Israel. Started Jan 2008; status: terminated.
02
Drugs
quetiapine
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00668265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00668265.